Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients-Reference-Cited by-同舟云学术

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients

Published:2018-03-15 Issue:5 Volume:11 Page:710-719
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Fouque Denis¹^ORCID,Roth Hubert²,Darné Bernadette³,Bouchet Jean-Louis⁴,Daugas Eric⁵,Drüeke Tilman B⁶,Hannedouche Thierry⁷,Jean Guillaume⁸,London Gérard M⁹

Affiliation:

1. Department of Nephrology, CH Lyon Sud, Univ Lyon, Lyon, France

2. Department of Nephrology, Centre de Recherche en Nutrition Humaine Rhône-Alpes, Pôle Recherche CHU-Grenoble, Inserm U1055-Bioénergétique, Université J. Fourier, Grenoble, France

3. Monitoring Force Group, Maisons-Laffitte, France

4. Centre de Traitement des Maladies Rénales Saint-Augustin, Bordeaux, France

5. HU-Paris Nord site Bichat, Paris, France

6. Inserm U1018, CESP, Université Paris-Saclay, Université Paris-Sud, UVSQ, Villejuif, France

7. Service de Néphrologie, Hôpitaux Universitaires de Strasbourg & Faculté de Médecine, Strasbourg, France

8. NephoCare, Tassin-Charcot, Sainte-Foy-lès-Lyon, France

9. Hôpital Manhes, Fleury-Mérogis, France

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/11/5/710/25843135/sfy015.pdf

Reference24 articles.

1. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

2. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease;Covic;Nephrol Dial Transplant,2009

3. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD);Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group;Kidney Int Suppl,2009

4. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease;National Kidney Foundation;Am J Kidney Dis,2003

5. Improving global outcomes in mineral and bone disorders;Moe;Clin J Am Soc Nephrol,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External validation of a 2-year all-cause mortality prediction tool developed using machine learning in patients with stage 4–5 chronic kidney disease;Journal of Nephrology;2024-07-04

2. A multivariate generalized linear model of the effect of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in end-stage renal disease;Current Issues in Pharmacy and Medical Sciences;2024-06-01

3. Global burden and influencing factors of chronic kidney disease due to type 2 diabetes in adults aged 20–59 years, 1990–2019;Scientific Reports;2023-11-19

4. Prediction of all-cause mortality for chronic kidney disease patients using four models of machine learning;Nephrology Dialysis Transplantation;2022-12-09

5. Mineral and bone disorder and longterm survival in a chronic kidney disease grade 3b-4cohort;Renal Failure;2022-08-10